Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryosuke Matsuda

Showing results (141-150 of 148) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 148 results.
World Neurosurgery|January 20, 2024
Clinical Results and Hematologic Predictors of Linear Accelerator-Based Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy for Brain Metastasis in Patients Aged 75 Years or Older: A Retrospective StudyRyosuke Matsuda, Masatoshi Hasegawa, Tetsuro Tamamoto, et al.
Brain Tumor Research and Treatment|May 12, 2026
Prognostic Value of EGFR Mutation Subtypes After Linac-Based Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy for Brain Metastasis From EGFR-Mutated Non-Small Cell Lung CancerRyosuke Matsuda, Shigeto Hontsu, Tetsuro Tamamoto, et al.
Current Oncology (Toronto, Ont.)|December 23, 2021
Salvage Surgical Resection after Linac-Based Stereotactic Radiosurgery for Newly Diagnosed Brain MetastasisRyosuke Matsuda, Takayuki Morimoto, Tetsuro Tamamoto, et al.
Journal of Neuro-Oncology|September 25, 2013
Cytotoxic human peripheral blood-derived γδT cells kill glioblastoma cell lines: implications for cell-based immunotherapy for patients with glioblastomaTsutomu Nakazawa, Mitsutoshi Nakamura, Young Soo Park, et al.
Journal of Neuro-Oncology|July 10, 2016
Antitumor effects of minodronate, a third-generation nitrogen-containing bisphosphonate, in synergy with γδT cells in human glioblastoma in vitro and in vivoTsutomu Nakazawa, Mitsutoshi Nakamura, Ryosuke Matsuda, et al.
Anticancer Research|September 9, 2018
Novel Human NK Cell Line Carrying CAR Targeting EGFRvIII Induces Antitumor Effects in Glioblastoma CellsToshiharu Murakami, Tsutomu Nakazawa, Atsushi Natsume, et al.
Current Oncology (Toronto, Ont.)|September 22, 2022
Long-Term Survival after Linac-Based Stereotactic Radiosurgery and Radiotherapy with a Micro-Multileaf Collimator for Brain MetastasisRyosuke Matsuda, Masatoshi Hasegawa, Tetsuro Tamamoto, et al.
Japanese Journal of Clinical Oncology|September 3, 2024
Cost of medical care for malignant brain tumors at hospitals in the Japan Clinical Oncology Group brain-tumor study groupKazuya Motomura, Keita Sasaki, Narushi Sugii, et al.
Pageof 15

Showing results (141-150 of 148) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 148 results.
World Neurosurgery|January 20, 2024
Clinical Results and Hematologic Predictors of Linear Accelerator-Based Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy for Brain Metastasis in Patients Aged 75 Years or Older: A Retrospective StudyRyosuke Matsuda, Masatoshi Hasegawa, Tetsuro Tamamoto, et al.
Brain Tumor Research and Treatment|May 12, 2026
Prognostic Value of EGFR Mutation Subtypes After Linac-Based Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy for Brain Metastasis From EGFR-Mutated Non-Small Cell Lung CancerRyosuke Matsuda, Shigeto Hontsu, Tetsuro Tamamoto, et al.
Current Oncology (Toronto, Ont.)|December 23, 2021
Salvage Surgical Resection after Linac-Based Stereotactic Radiosurgery for Newly Diagnosed Brain MetastasisRyosuke Matsuda, Takayuki Morimoto, Tetsuro Tamamoto, et al.
Journal of Neuro-Oncology|September 25, 2013
Cytotoxic human peripheral blood-derived γδT cells kill glioblastoma cell lines: implications for cell-based immunotherapy for patients with glioblastomaTsutomu Nakazawa, Mitsutoshi Nakamura, Young Soo Park, et al.
Journal of Neuro-Oncology|July 10, 2016
Antitumor effects of minodronate, a third-generation nitrogen-containing bisphosphonate, in synergy with γδT cells in human glioblastoma in vitro and in vivoTsutomu Nakazawa, Mitsutoshi Nakamura, Ryosuke Matsuda, et al.
Anticancer Research|September 9, 2018
Novel Human NK Cell Line Carrying CAR Targeting EGFRvIII Induces Antitumor Effects in Glioblastoma CellsToshiharu Murakami, Tsutomu Nakazawa, Atsushi Natsume, et al.
Current Oncology (Toronto, Ont.)|September 22, 2022
Long-Term Survival after Linac-Based Stereotactic Radiosurgery and Radiotherapy with a Micro-Multileaf Collimator for Brain MetastasisRyosuke Matsuda, Masatoshi Hasegawa, Tetsuro Tamamoto, et al.
Japanese Journal of Clinical Oncology|September 3, 2024
Cost of medical care for malignant brain tumors at hospitals in the Japan Clinical Oncology Group brain-tumor study groupKazuya Motomura, Keita Sasaki, Narushi Sugii, et al.
Pageof 15